Drug intelligence / Profile preview

lauromacrogols + urea (Almirall)

Development stage
Unknown
Lead developer
Almirall
Modality
Small Molecules
Administration
Topical
01

Overview

Balneum Plus cream is a topical over-the-counter combination cream developed by Almirall containing 3% lauromacrogols (polidocanol) and 5% urea. It is primarily used to treat dry, itchy skin conditions such as atopic dermatitis, eczema, and psoriasis. Lauromacrogols act as a local anesthetic and antipruritic agent by inhibiting voltage-gated sodium channels (such as Nav1.7 and Nav1.3) to relieve itching, while urea acts as a humectant and keratolytic agent to hydrate the stratum corneum and restore the skin's natural barrier. The formulation was also investigated in a Phase 4 clinical trial (the 'DON'T ITCH' trial) sponsored by Portsmouth Hospitals NHS Trust for the treatment of chronic kidney disease-associated pruritus (uraemic pruritus) in adult haemodialysis patients, though it did not show a significant difference in itch scores compared to the emollient control.

Brand names
Balneum PlusBalneum Plus creamOptidermE45 Itch Relief CreamE-45 Itch Relief CreamE 45 Itch Relief CreamPruri-med
Other names
polidocanol + urealauromacrogols + ureaurea + lauromacrogolsurea + polidocanol
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on lauromacrogols + urea (Almirall).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lauromacrogols + urea (Almirall).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call